<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6748749</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btz118</article-id>
    <article-id pub-id-type="publisher-id">btz118</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Structural Bioinformatics</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>3DBIONOTES v3.0: crossing molecular and structural biology data with genomic variations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Segura</surname>
          <given-names>Joan</given-names>
        </name>
        <xref ref-type="corresp" rid="btz118-cor1"/>
        <!--<email>jsegura@cnb.csic.es</email>-->
        <xref ref-type="aff" rid="btz118-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6156-3542</contrib-id>
        <name>
          <surname>Sanchez-Garcia</surname>
          <given-names>Ruben</given-names>
        </name>
        <xref ref-type="aff" rid="btz118-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sorzano</surname>
          <given-names>C O S</given-names>
        </name>
        <xref ref-type="aff" rid="btz118-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Carazo</surname>
          <given-names>J M</given-names>
        </name>
        <xref ref-type="aff" rid="btz118-aff1"/>
      </contrib>
    </contrib-group>
    <aff id="btz118-aff1"><institution>Spanish National Institute for Bioinformatics (INB ELIXIR-ES) and Biocomputing Unit, National Centre of Biotechnology (CSIC)/Instruct Image Processing Centre</institution>, Madrid, Spain</aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btz118-cor1">To whom correspondence should be addressed. E-mail: <email>jsegura@cnb.csic.es</email>, <email>jsegurmor@gmail.com</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-02-15">
      <day>15</day>
      <month>2</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>2</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>35</volume>
    <issue>18</issue>
    <fpage>3512</fpage>
    <lpage>3513</lpage>
    <history>
      <date date-type="received">
        <day>17</day>
        <month>12</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>12</month>
        <year>2018</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>2</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btz118.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Many diseases are associated to single nucleotide polymorphisms that affect critical regions of proteins as binding sites or post translational modifications. Therefore, analysing genomic variants with structural and molecular biology data is a powerful framework in order to elucidate the potential causes of such diseases.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>A new version of our web framework 3DBIONOTES is presented. This version offers new tools to analyse and visualize protein annotations and genomic variants, including a contingency analysis of variants and amino acid features by means of a Fisher exact test, the integration of a gene annotation viewer to highlight protein features on gene sequences and a protein–protein interaction viewer to display protein annotations at network level.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The web server is available at <ext-link ext-link-type="uri" xlink:href="https://3dbionotes.cnb.csic.es">https://3dbionotes.cnb.csic.es</ext-link></p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
      <sec id="s5">
        <title>Contact</title>
        <p>Spanish National Institute for Bioinformatics (INB ELIXIR-ES) and Biocomputing Unit, National Centre of Biotechnology (CSIC)/Instruct Image Processing Centre, C/ Darwin nº 3, Campus of Cantoblanco, 28049 Madrid, Spain.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Ministerio de Economía, Industria y Competitividad, Gobierno de España</named-content>
          <named-content content-type="funder-identifier">10.13039/501100010198</named-content>
        </funding-source>
        <award-id>BIO2016-76400-R(AEI/FEDER, UE)</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Comunidad de Madrid</named-content>
          <named-content content-type="funder-identifier">10.13039/100012818</named-content>
        </funding-source>
        <award-id>S2017/BMD-3817</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Instituto de Salud Carlos III</named-content>
          <named-content content-type="funder-identifier">10.13039/501100004587</named-content>
        </funding-source>
        <award-id>PT13/0001/0009</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">INB</named-content>
        </funding-source>
        <award-id>PT17/0009/0010 - ISCIII-SGEFI/ERDF</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Horizon 2020</named-content>
          <named-content content-type="funder-identifier">10.13039/100010661</named-content>
        </funding-source>
        <award-id>Elixir – EXCELERATE INFRADEV-3-2015, Proposal 676559</award-id>
        <award-id>INFRAIA-1-2014-2015, Proposal 653706</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Ministerio de Ciencia, Innovación y Universidades, Gobierno de España</named-content>
        </funding-source>
        <award-id>E-28-2018-0015407</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Ministerio de Educación, Cultura y Deporte</named-content>
          <named-content content-type="funder-identifier">10.13039/501100003176</named-content>
        </funding-source>
        <award-id>FPU-2015/264</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="2"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Next-generation sequencing has flooded many databases with biomedical data where single-nucleotide variations are associated with phenotypes or diseases (<xref rid="btz118-B10" ref-type="bibr">Zerbino <italic>et al.</italic>, 2018</xref>). This information comprises collections of variant–disease pairs that can be used to infer which genomic variations might be involved in a particular disease. However, changes on the biochemical or structural features of the affected amino acids (if applicable) can be more informative in order to understand the causes of diseases. For that reason, some of the existent resources compiling variant–disease knowledge also annotates protein residues with biochemical features displaying what properties could be affected (<xref rid="btz118-B2" ref-type="bibr">Dingerdissen <italic>et al.</italic>, 2018</xref>).</p>
    <p>In this work, we present a new version of 3DBIONOTES (<xref rid="btz118-B6" ref-type="bibr">Segura <italic>et al.</italic>, 2017</xref>; <xref rid="btz118-B8" ref-type="bibr">Tabas-Madrid <italic>et al.</italic>, 2016</xref>) where different analysis tools and viewers have been integrated to find how genomic variants may affect the different protein residues. 3DBIONOTES is a web framework that integrates biological annotations and structural information of proteins from multiple sources (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S1</xref>). In this version the application computes Fisher’s exact test in order to find what biochemical or structural features are statistically affected by the variants associated to a particular disease. Moreover, a new panel displays those annotated regions where the co-occurrence between protein features and variants are statistically enriched. In addition, a gene annotation viewer has been fully integrated to display protein features at gene level. Also, a protein–protein interaction (PPI) viewer has been included in such a way that the different annotations can be displayed at network level. Finally, and as an additional tool, a new type of query, request by set of proteins, has been implemented to explore and analyse PPI networks. Moreover, custom annotations, including variants, can be submitted and analysed with the biological features integrated in the application.</p>
  </sec>
  <sec>
    <title>2 New features</title>
    <sec>
      <title>2.1 Gene annotation viewer</title>
      <p>In this version of 3DBIONOTES, a gene annotation viewer has been fully integrated (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S2</xref>). This panel displays gene information from ENSEMBL database (<xref rid="btz118-B10" ref-type="bibr">Zerbino <italic>et al.</italic>, 2018</xref>); the collected information includes: introns, exons, codifying regions and genomic variants. Moreover, ENSEMBL gene sequences are aligned with UniProt (<xref rid="btz118-B9" ref-type="bibr">UniProt Consortium, 2018</xref>) and PDB (<xref rid="btz118-B1" ref-type="bibr">Burley <italic>et al.</italic>, 2018</xref>) amino acids in such a way that protein annotated regions can be highlighted on gene sequences and vice versa (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S2</xref>).</p>
    </sec>
    <sec>
      <title>2.2 Genomic variants contingency analysis</title>
      <p>In order to find which protein regions are statistically affected by the genomic variants associated to a particular disease, Fisher’s exact test between the different annotations and the variants associated to the different diseases is computed. The main objective is to find co-occurrence of protein residues between the different structural or biochemical annotations and the variants associated to diseases. For example, most cancer related variants of the KRAS human protein map on its nucleotide binding region (see Section 3.1 and <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S3</xref>).</p>
    </sec>
    <sec>
      <title>2.3 Exploring PPI networks</title>
      <p>A new type of query to request information for a set of proteins is now available. Moreover, a panel to visualize PPI networks using a graph-based representation has been integrated. This panel displays the physical binding between proteins when the information for a multimeric entry is requested or the PPIs that have been experimentally observed when a given set of proteins is submitted. In the first case, the contacts are computed using a distance threshold of 6 Å between heavy atoms. For the second case, PPI data is collected from Interactome3D (<xref rid="btz118-B3" ref-type="bibr">Mosca <italic>et al.</italic>, 2013</xref>). Moreover, the network panel can display annotations at network level using a similar approach as dSysMap (<xref rid="btz118-B4" ref-type="bibr">Mosca <italic>et al.</italic>, 2015</xref>) (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S4</xref>).</p>
    </sec>
    <sec>
      <title>2.4 Submitting custom annotations</title>
      <p>The application supports the submission of custom data in such a way that users can analyse their own genomic variants or other annotations and compare them with 3DBIONOTES integrated data. The submitted information is fully integrated and the different visualization and analysis tools can be used to display and process the external data.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Use cases</title>
    <sec>
      <title>3.1 Analysis on the human KRAS genomic variants</title>
      <p>In this example we have analysed the genomic variants associated to KRAS human protein (UniProt accession P01116). KRAS protein is a GTPase that acts as a signalling switch in many transduction pathways including cell proliferation. The active state of KRAS occurs when the protein is bound to GTP. In this state, the protein recruits and activates other growth factors and cell signalling receptors. Upon GTP hydrolysis and conversion to GDP, KRAS is inactivated. KRAS mutations are known to be involved in different diseases such as multiple cancer types or neurofibromatosis (<xref rid="btz118-B7" ref-type="bibr">Simanshu, et al., 2017</xref>). We used 3DBIONOTES to analyse the co-occurrence of KRAS variants associated to diseases with the different biochemical annotations. The main reason was to check whether those variants occur in particular regions of KRAS or randomly distributed. <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S4</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S1 and S2</xref> display the analysis panel of 3DBIONOTES and clearly show that many of those variants occur in the ‘Nucleotide Binding Site’ annotated regions. KRAS acts as on/off switch in many processes and its active or inactive form depends on the interaction with GTP or GDP, respectively. Then, mutations affecting KRAS GTP/GDP-binding sites may affect its activation and therefore, many cell regulatory processes.</p>
    </sec>
    <sec>
      <title>3.2 GNB1 neurodevelopmental disability</title>
      <p>This example illustrates how 3DBIONOTES can be used to analyse external variants. We have collected the variants of the G protein subunit beta (GNB1) associated to neurodevelopmental delay, hypotonia and seizures available in the work of <xref rid="btz118-B5" ref-type="bibr">Petrovski <italic>et al.</italic> (2016)</xref> (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). GNB1 protein modulates transmembrane signalling pathways controlled by G protein-coupled receptors. We have requested the PPI network information for the GNB1 protein (UniProt accession P62873) and attached the collected variants to 3DBIONOTES. When the variants are mapped to the PPI network, many of them appear affecting the binding sites between GNB1 and other G proteins. Moreover, the contingency analysis identified that the co-occurrence between many of the GNB1-biding sites and the submitted variants was statistically significant (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S8</xref>). Consequently, mutations of the GNB1-binding sites may affect the interaction with other G proteins and, thus, some of the cell signalling pathways involving G proteins.</p>
    </sec>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by Ministerio de Economía, Industria y Competitividad, Gobierno de España [grant No. BIO2016-76400-R(AEI/FEDER, UE)]; Comunidad de Madrid [grant No. S2017/BMD-3817]; Instituto de Salud Carlos III [grant No. PT13/0001/0009; INB Grant PT17/0009/0010 - ISCIII-SGEFI/ERDF]; Horizon 2020 [grant No. Elixir – EXCELERATE INFRADEV-3-2015, Proposal 676559] and iNEXT [INFRAIA-1-2014-2015, Proposal 653706]; Ministerio de Ciencia, Innovación y Universidades, Gobierno de España [Juan de la Cierva-E-28-2018-0015407 to J.S.]; and Ministerio de Educación, Cultura y Deporte [FPU-2015/264 to R.S.-G.].</p>
    <p><italic>Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>btz118_Supplementary_Material</label>
      <media xlink:href="btz118_supplementary_material.doc">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btz118-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burley</surname><given-names>S.K.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy</article-title>. <source>Nucleic Acids Res</source>, <volume>47</volume>, <fpage>D464</fpage>–<lpage>D474</lpage>.</mixed-citation>
    </ref>
    <ref id="btz118-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dingerdissen</surname><given-names>H.M.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D1128</fpage>–<lpage>D1136</lpage>.<pub-id pub-id-type="pmid">30053270</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosca</surname><given-names>R.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Interactome3D: adding structural details to protein networks</article-title>. <source>Nat. Methods</source>, <volume>10</volume>, <fpage>47</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">23399932</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosca</surname><given-names>R.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>dSysMap: exploring the edgetic role of disease mutations</article-title>. <source>Nat. Methods</source>, <volume>12</volume>, <fpage>167</fpage>–<lpage>168</lpage>.<pub-id pub-id-type="pmid">25719824</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrovski</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures</article-title>. <source>Am. J. Hum. Genet</source>., <volume>98</volume>, <fpage>1001</fpage>–<lpage>1010</lpage>.<pub-id pub-id-type="pmid">27108799</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Segura</surname><given-names>J.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>3DBIONOTES v2.0: a web server for the automatic annotation of macromolecular structures</article-title>. <source>Bioinformatics</source>, <volume>33</volume>, <fpage>3655</fpage>–<lpage>3657</lpage>.<pub-id pub-id-type="pmid">28961691</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simanshu</surname><given-names>D.K.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>RAS proteins and their regulators in human disease</article-title>. <source>Cell</source>, <volume>170</volume>, <fpage>17</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">28666118</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabas-Madrid</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>3DBIONOTES: a unified, enriched and interactive view of macromolecular information</article-title>. <source>J. Struct. Biol</source>., <volume>194</volume>, <fpage>231</fpage>–<lpage>234</lpage>.<pub-id pub-id-type="pmid">26873783</pub-id></mixed-citation>
    </ref>
    <ref id="btz118-B9">
      <mixed-citation publication-type="journal">UniProt Consortium. (<year>2018</year>) 
<article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D506</fpage>–<lpage>D515</lpage>.</mixed-citation>
    </ref>
    <ref id="btz118-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zerbino</surname><given-names>D.R.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>Ensembl 2018</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D754</fpage>–<lpage>D761</lpage>.<pub-id pub-id-type="pmid">29155950</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
